TIMM8A and neoplasm: The findings in this report elucidate the important role of TIMM8A in BRCA and UCEC, provide potential relationships and underlying mechanisms between TIMM8A and tumor-immune interactions, and provide insights into the use of anti-PD-L1 therapy in BRCA and UCEC.